secwatch.observer — SEC 8-K summary
======================================

Issuer:     Autolus Therapeutics plc (AUTL)
CIK:        0001730463
Form:       8-K
Filed at:   2025-06-02T23:59:59+00:00
Accession:  0001730463-25-000043
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Autolus sets AGM for June 26; two directors to step down; new equity plan proposed
--------------------------------------------------------------------------------

- AGM on June 26, 2025; resolutions include adoption of 2024 accounts, auditor reappointment (EY LLP), and director re-elections.
- Directors Joseph Anderson and Martin Murphy will not stand for re-election, ending their terms after the AGM.
- New Employee Share Purchase Plan with Sharesave Sub-Plan (up to 3M shares) approved by Board on May 20, 2025, subject to shareholder approval.
- Remuneration report and policy, plus re-election of Dr. Robert Iannone and Dr. Ravi Rao, also on the agenda.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1730463/000173046325000043/0001730463-25-000043-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1730463/000173046325000043/autl-20250602.htm
  HTML page:      https://secwatch.observer/filing/0001730463-25-000043

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer